Key result
Moderate-to-severe hepatosteatosis linked to ~17-fold higher prevalence of severe CAD.
Why the study?
Nonalcoholic fatty liver disease has been shown to be associated with CAD, but its association with the presence and severity of CAD needed evaluation.
Does ultrasonographically detected hepatosteatosis predict the presence and severity of coronary artery disease in patients undergoing coronary angiography?
Cross-Sectional (n=153)
No
Does ultrasonographically detected hepatosteatosis predict the presence and severity of coronary artery disease in patients undergoing coronary angiography?
Absolute Event Rate: 90% vs 5.3%
p-value: p=<0.001
Ultrasonographically detected hepatosteatosis is significantly associated with the presence and severity of coronary artery disease, suggesting its utility as an independent risk marker.
Moderate-to-severe hepatosteatosis was associated with severe CAD; leaves open its independent predictive value pending prospective studies.
Background: Nonalcoholic fatty liver disease (NAFLD) has shown to be associated with coronary artery disease (CAD). Objectives: The aim of our study was to evaluate the association between the presence and severity of CAD and NAFLD. Methods: The study group consisted of 153 patients who underwent coronary angiographies. Patients were categorized into CAD and non-CAD groups. CAD severity was determined by the number of CAD-involved arteries and the vessel score multiplied by Gensini score, the latter judging CAD severity. Fatty liver was diagnosed by abdominal ultrasonography (USG), with the patients being categorized by the degree of hepatosteatosis, as Grade 0, Grade 1, and Grade 2-3. Results: Among the whole study population, 47.1% of patients (n=72) were female and 52.9% of patients (n=81) were male. Forty-three patients had normal coronary arteries; 27 patients had non-critical CAD and side branch disease; and 83 patients had clinically significant CAD (stenosis>50%). The rate of CAD and Gensini score were significantly different between Grade 0, 1 and 2-3 hepatosteatosis groups (p<0.05). Patients with CAD had a significantly higher AST level than those without (p< 0.05). Conclusions: Ultrasonographically detected hepatosteatosis independently predicts the presence and severity of CAD.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2022) conducted a cross-sectional in Coronary artery disease and Nonalcoholic fatty liver disease (n=153). Grade 2-3 hepatosteatosis vs. Grade 0-1 hepatosteatosis was evaluated on Gensini score > 36 (moderate-to-severe coronary artery disease) (p=<0.001). Ultrasonographically detected moderate-to-severe hepatosteatosis (Grade 2-3) was significantly associated with a higher prevalence of severe coronary artery disease compared to Grade 0-1 hepatosteatosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: